Methodologically rigorous risk of bias tools for nonrandomized studies had low reliability and high evaluator burden.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
12 2020
Historique:
received: 01 07 2020
revised: 09 09 2020
accepted: 22 09 2020
pubmed: 29 9 2020
medline: 15 4 2021
entrez: 28 9 2020
Statut: ppublish

Résumé

To assess the real-world interrater reliability (IRR), interconsensus reliability (ICR), and evaluator burden of the Risk of Bias (RoB) in Nonrandomized Studies (NRS) of Interventions (ROBINS-I), and the ROB Instrument for NRS of Exposures (ROB-NRSE) tools. A six-center cross-sectional study with seven reviewers (2 reviewer pairs) assessing the RoB using ROBINS-I (n = 44 NRS) or ROB-NRSE (n = 44 NRS). We used Gwet's AC For ROBINS-I, both IRR and ICR for individual domains ranged from poor to substantial agreement. IRR and ICR on overall RoB were poor. The evaluator burden was 48.45 min (95% CI 45.61 to 51.29). For ROB-NRSE, the IRR and ICR for the majority of domains were poor, while the rest ranged from fair to perfect agreement. IRR and ICR on overall RoB were slight and poor, respectively. The evaluator burden was 36.98 min (95% CI 34.80 to 39.16). We found both tools to have low reliability, although ROBINS-I was slightly higher. Measures to increase agreement between raters (e.g., detailed training, supportive guidance material) may improve reliability and decrease evaluator burden.

Identifiants

pubmed: 32987166
pii: S0895-4356(20)31119-7
doi: 10.1016/j.jclinepi.2020.09.033
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Maya M Jeyaraman (MM)

George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada. Electronic address: maya.jeyaraman@umanitoba.ca.

Rasheda Rabbani (R)

George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.

Leslie Copstein (L)

George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.

Reid C Robson (RC)

Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario M5B 1T8, Canada.

Nameer Al-Yousif (N)

George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.

Michelle Pollock (M)

Institute of Health Economics, 1200-10405 Jasper Avenue, Edmonton, Alberta T5J 3N4, Canada.

Jun Xia (J)

Nottingham Ningbo GRADE Centre, The University of Nottingham, Ningbo, 199 East Taikang Road, Ningbo, China; Division of Epidemiology and Public Health, School of Medicine, University of Nottingham Medical School, Nottingham, NG7 2UH, UK.

Chakrapani Balijepalli (C)

Pharmalytics Group, 422 Richards St, Suite 170, Vancouver, Canada.

Kimberly Hofer (K)

Centre Hospitalier de l'Université de Montreal, 1000, St Denis St, Montreal, Quebec H2X 0C1, Canada; Faculty of Medicine, Department of Medicine, Université de Montréal, Roger-Gaudry Building, 2900 Edouard Montpetit Blvd, Montreal, Quebec H3T 1J4, Canada; Centre de recherche du Centre, Hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, Quebec H2X 0A9, Canada.

Samer Mansour (S)

Centre Hospitalier de l'Université de Montreal, 1000, St Denis St, Montreal, Quebec H2X 0C1, Canada; Faculty of Medicine, Department of Medicine, Université de Montréal, Roger-Gaudry Building, 2900 Edouard Montpetit Blvd, Montreal, Quebec H3T 1J4, Canada; Centre de recherche du Centre, Hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, Quebec H2X 0A9, Canada.

Mir S Fazeli (MS)

Evidinno Outcomes Research Inc., 1750 Davie Street, Suites 601 & 602, Vancouver, British Columbia V6G 1W3, Canada.

Mohammed T Ansari (MT)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada.

Andrea C Tricco (AC)

Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria St, Toronto, Ontario M5B 1T8, Canada; Epidemiology Division, Dalla Lana School of Public Health & Institute of Health, Management, and Policy Evaluation, University of Toronto, 27 King's College Circle, Toronto, Ontario M5S 1A1, Canada; Queen's Collaboration for Health Care Quality, Joanna Briggs Institute Centre of Excellence, Queen's University, 92 Barrie Street, Room 214, Kingston, Ontario, K7L 3N6, Canada.

Ahmed M Abou-Setta (AM)

George & Fay Yee Center for Healthcare Innovation, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH